The inhibitory effects of low-dose ionizing radiation in IgE-mediated allergic responses

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Joo, Hae Mi ^a   Kang, Su Jin ^a   Nam, Seon Young ^a   Yang, Kwang Hee ^a   Kim, Cha Soon ^a   Lee, In Kyung ^a   Kim, Ji Young ^a   Hogan, Simon Patrick ^b  

^a Korea Hydro & Nuclear Power Co   (South Korea)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; FC EPSILON RECEPTOR RI; FC RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE C; PROTEIN KINASE LYN; PROTEIN KINASE SYK; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOGLOBULIN E RECEPTOR; LYN PROTEIN-TYROSINE KINASE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SYK PROTEIN, HUMAN; SYK PROTEIN, MOUSE;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL DEATH; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; IONIZING RADIATION; LOW ENERGY RADIATION; MAST CELL; MEDIATOR RELEASE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; SKIN ALLERGY; SKIN ANAPHYLAXIS; SKIN MANIFESTATION; ANIMAL; C57BL MOUSE; CALCIUM SIGNALING; CELL LINE; GENETICS; IMMUNOLOGY; METABOLISM; PASSIVE SKIN ANAPHYLAXIS; RADIATION RESPONSE;

ANIMALS; CALCIUM SIGNALING; CELL LINE; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MICE; MICE, INBRED C57BL; PASSIVE CUTANEOUS ANAPHYLAXIS; PHOSPHOLIPASE C GAMMA; PROTEIN-TYROSINE KINASES; RADIATION, IONIZING; RECEPTORS, IGE; SRC-FAMILY KINASES; SYK KINASE;

EID: 84943339670     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136394     Document Type: Article

References (31)

1. Luckey TD, Lawrence KS. Radiation hormesis: the good, the bad, and the ugly. Dose-response 2006; 4(3): 169-190. doi:10.2203/dose-response.06-102.Luckey PMID: 18648595
2. Doss M. Linear NO-threshold model vs. radiation hormesis. Dose-response 2013; 11: 95-512.
3. Harrington NP, Chambers KA, Ross WM, Filion LG. Radiation damage and immune suppression in splenic mononuclear cell population. Clin. Exp. Immunol. 1997; 107: 417-424. PMID: 9030884
4. Akiyama M. Late effects of radiation on the human immune system: an overview of immune response among the atomic-bomb survivors. Int. J. Rad. Biol. 1995; 107: 417-424.
5. Berk LD, Hodes PJ. Roentgen therapy for infections: an historical review. Yale J. Biol. Med. 1991; 64: 155-165. PMID: 1750226
6. Scott SG. Method of treating asthma by radiation. Br. Med. J. 1926; 1(3416): 939-941.
7. Bogoljubov WM. Clinical aspects of radon therapy in the U.S.S.R. J. Phys. Med. Balneol. Med. Klimatol. 1988; 17: 59-70.
8. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat. Immunol. 2008; 9(11): 1215-1223. doi:10.1038/ni.f.216 PMID: 18936782
9. Weller K, Foitzik K, Paus R, Syska W, Maurer M. Mast cells are required for normal healing of skin wounds in mice. FASEB J. 2006; 20(13): 2366-2368. PMID: 16966487
10. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 2006; 117:1277-1284. PMID: 16750987
11. Ott VL, Cambier JC, Kappler J, Marrack P, Awanson BJ. Mast cell-dependent migration of effector CD8 + T cells through production of leukotriene B4. Nat. Immunol. 2003; 4(10): 974-981. PMID: 12949532
12. Gilfillan AM, Tkaczyk C. Integrated signaling pathways for mast-cell activation. Nat. Rev. Immunol. 2006; 6(3): 218-230. PMID: 16470226
13. Sagi-Eisenberg R. The mast cell: where endocytosis and regulated exocytosis meet. Immunol. Rev. 2007; 217: 292-303. PMID: 17498067
14. Ray MC, Tharp MD, Sullivan TJ, Tigelaar RE. Contact hypersensitivity reactions to dinitrofluoroben-zene mediated by monoclonal IgEanti-DNP antibodies. J. Immunol. 1983; 131:1096-1102. PMID: 6193174
15. Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock JJ. Late cutaneous allergic responses in isolated IgE-dependent reactions. J. Allergy Clin. Immunol. 1973;52:38-46. PMID: 4577089
16. Katayama I, Tanei R, Yokozeki H, Nishioka K, Dohi Y. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/C mice by monoclonal anti-DNP IgE antibody: possible implications for skin lesion formation in atopic dermatitis. Int. Arch. Allergy Appl. Immunol. 1990; 93: 148-154. PMID: 1983077
17. Nagai H, Sakurai T, Inagaki N, Mori H. An immunopharmacological study of the biphasic allergic skin reaction in mice. J. Allergy Clin. Immunol. 1995; 52: 38-46.
18. Solley GO, Gleich G, Jordan R, Schroeter A. The late phase of the immediate wheal and flare skin reaction. Its dependence on IgE antibodies. J. Clin. Invest. 1976; 58: 408-420. PMID: 783199
19. Schleimer RP, Fox CC, Naclerio RM, Plaut M, Warner JA, Kagey-Sobotka A, et al. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J. Allergy Clin. Immunol. 1985; 76: 369-374. PMID: 2410478
20. Joo HM, Nam SY, Yang KH, Kim CS, Jin YW, Kim JY. The effects of low-dose ionizing radiation in the activated rat basophilic leukemia (RBL-2H3) mast cell. J. Biol. Chem. 2012; 287: 27789-27795. doi:10.1074/jbc.M112.378497 PMID: 22700973
21. Weber S, Babina M, Kruger-Krasagakers S, Grutzkau A, Henz BM. A subclone (5C6)of the human mast cell line HMC-1 represents a more differentiated phenotype than original cell line. Arch. Dermatol. Res. 1996; 288: 778-782. PMID: 8950460
22. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leu. Res. 2003; 27: 677-682.
23. Tada H, Shiho O, Kuroshima K, Koyama M, Tsukamoto K. An improved colorimetric assay for interleukin 2. J. Immunol. Methods 1986; 93:157-165. PMID: 3490518
24. Yang YJ, Chen W, Edger A, Li B, Molkentin JD, Berman JN, et al. Rcan1 negatively regulates FcεRI-mediated signaling and mast cell function. J. Exp. Med. 2009; 206:195-207. doi:10.1084/jem. 20081140 PMID: 19124655
25. Guhl S, Babina M, Neou A, Zuberbier T, Artuc M. Mast cell lines HMC-1 and LAD2in comparison with mature human skin mast cells - drastically reduced levels oftryptase and chymase in mast cell lines. Exp. Dermatol. 2010; 1-3.
26. Wershil BK, Wang ZS, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum againsttumor necrosis factor-alpha. J. Clin. Invest. 1991;87:446-453. PMID: 1991831
27. Nagai H, Abe T, Yamaguchi I, Mito K, Tsunematsu M, Kimata M, et al. Role of mast cells in the onset of IgE-mediated late-phase cutaneous response in mice. J. Allergy Clin. Immunol. 2000; 106: S91-S98. PMID: 10887340
28. Gelich GJ. The late phase of the immunoglobulin Emediated reaction: A link between anaphylaxis and common allergic disease. J. Allergy Clin. Immunol. 1982; 70:160-166. PMID: 6125535
29. Kaliner MM. Hypotheses on the contribution of late-phase allergic responses to the understanding and treatment of allergic disease. J. Allergy Clin. Immunol. 1984; 73: 311-315. PMID: 6366029
30. Charlesworth EN, Hood AF, Sorer NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J. Clin. Invest. 1989; 83:1519-1526. PMID: 2468688
31. Abrevaya XC, Carballo MA, Mudry MD. The bone marrow micronucleus test and metronidazole genotoxicity in different strains of mice (Mus musculus). Genetics and Mol. Biol. 2007; 30:1139-1143.